Frazier Life Sciences Management’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Hold |
|
|||||
|
2025
Q1 | $7.17M | Hold |
|
|||||
|
2024
Q4 | $10.9M | Hold |
|
|||||
|
2024
Q3 | $16.8M | Hold |
|
|||||
|
2024
Q2 | $16.1M | Hold |
|
|||||
|
2024
Q1 | $29.5M | Buy |
|
|||||
|
2023
Q4 | $24.1M | Hold |
|
|||||
|
2023
Q3 | $8.73M | Hold |
|
|||||
|
2023
Q2 | $8.92M | Hold |
|
|||||
|
2023
Q1 | $6.89M | Hold |
|
|||||
|
2022
Q4 | $7.12M | Hold |
|
|||||
|
2022
Q3 | $8.02M | Hold |
|
|||||
|
2022
Q2 | $10.6M | Hold |
|
|||||
|
2022
Q1 | $15.6M | Buy |
|